| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/14/2008 | US20080193949 Using selectin concentration as diagnostic indicator of thrombosis |
| 08/14/2008 | US20080193944 Expression vector comprising nucleotide sequences coding cardiac-related ankyrin-repeat protein kinase (CARK) for diagnosis, treatment and prevention of cardiovascular disorders |
| 08/14/2008 | US20080193912 Disruption microbial cell from bodily fluid samples to release nucleic acid; lysozyme lysing, EDTA chelation, incubating, isolate with chaotropic agent, detergent, nucleic acid-binding support; for high-throughput automated systems; single reaction vessel, does not require mechanical or physical shearing |
| 08/14/2008 | US20080193577 Antibacterial Substance Dm0507 and Utilization of the Same |
| 08/14/2008 | US20080193557 Contacting teeth surface with amorphous mixture of calcium phosphate and calcium fluorophosphate with protein disruption agents such as phosphoprotein |
| 08/14/2008 | US20080193554 Surgical Membrane |
| 08/14/2008 | US20080193541 Particulate aqueous system for the preparation of a formulation for the treatment of adipose diseases |
| 08/14/2008 | US20080193540 Solid, Oral Drug Form Which Has Been Designed to Prevent Misuse |
| 08/14/2008 | US20080193539 Novel Stabilized Carotenoid Compositions |
| 08/14/2008 | US20080193518 3-[2-(3-tert-Butyl-ureido)-3,3-dimethyl-butyryl]-6,6-dimethyl-3-aza-bicyclo[3.1.0]hexane-2-carboxylic acid (2-carbamoyl-1-cyclobutylmethyl-2-oxo-ethyl)-amide; Solvent-anti-solvent precipitation; hepatitis C virus protease inhibitors |
| 08/14/2008 | US20080193465 Human Monoclonal Antibodies that Specifically Bind Igf-II |
| 08/14/2008 | US20080193459 Treatment of fungal infections with polyene or beta glucan synthase inhibitor anti-fungals combined with anti HSP90 antibodies |
| 08/14/2008 | US20080193457 Major histocompatibility complex peptide for use in treatment and prevention of rheumatoid arthritis (RA) |
| 08/14/2008 | US20080193456 Glucan conjugated monoclonal antibody for use in treatment and prevention of cell proliferative disorders; antitumor agents |
| 08/14/2008 | US20080193455 Placental growth factor (PIGF) specific immunoglobulin for use in treatment and prevention of pathollogical angiogenesis |
| 08/14/2008 | US20080193454 Identification of Surface-Associated Antigens for Tumor Diagnosis and Therapy |
| 08/14/2008 | US20080193453 Anti Tfr Antibody |
| 08/14/2008 | US20080193447 Gamma-1 and gamma-3 anti-human cd23 monoclonal antibodies and use thereof as therapeutics |
| 08/14/2008 | US20080193427 Means and Methods for Preventing and/or Treating Caries |
| 08/14/2008 | US20080193421 Producing tissue and organ culture systems using multicellular mammalian cell aggregates by forming organoid bodies of three-dimensional multicellular mammalian cell aggregates by aggregation and differentiation of multi- or pluripotent adult stem cells; bodies contain two different differentiated cells |
| 08/14/2008 | US20080193383 administering delta receptor angonists such as diarylmethyl piperazine and diarylmethyl piperidine compounds; side effect reduction of anesthetics, barbiturates and analgesics |
| 08/14/2008 | US20080193374 a solution comprising alpha ray emitters and chemotherapeutic agents, encapsulated in lipids, used as anticarcinogenic agents |
| 08/14/2008 | CA2678193A1 Aza-bridged-ring compound |
| 08/14/2008 | CA2677995A1 Acylguanidine derivative |
| 08/14/2008 | CA2677661A1 Tricyclic compounds |
| 08/14/2008 | CA2677657A1 Agent for preventing bleeding from cerebral cortical vein |
| 08/14/2008 | CA2676300A1 Cellulose derivative and method for production thereof |
| 08/13/2008 | EP1956093A1 von Willebrand Factor (vWF)-cleaving protease |
| 08/13/2008 | EP1956090A1 Novel protein and dna encoding the protein |
| 08/13/2008 | EP1956030A1 Secreted and transmembrane polypeptides and nucleic acids endoding the same |
| 08/13/2008 | EP1956020A2 1-[2-(heterocyclyl-aminomethyl)-piperidin-1-YL]-1-(2-methyl-5-phenyl-heterocyclyl)-methanone derivatives and related compounds as orexin-1 antagonists for the treatment of obesity |
| 08/13/2008 | EP1956017A1 Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and method of reducing TNF alpha levels |
| 08/13/2008 | EP1956009A1 Aromatic compound |
| 08/13/2008 | EP1956004A1 Quinoline derivatives and their use as 5-HT6 ligands |
| 08/13/2008 | EP1956001A1 Pharmaceutical for use in the treatment of ureterolithiasis |
| 08/13/2008 | EP1955715A1 Use of Sirt7 for treating age-related diseases |
| 08/13/2008 | EP1955703A1 Viruses for the treatment of cellular proliferative disorders |
| 08/13/2008 | EP1955696A2 Use of EDG receptor binding agents in cancer |
| 08/13/2008 | EP1954322A2 Mitochondria-targeted antioxidant prodrugs and methods of use |
| 08/13/2008 | EP1541558B1 Heterocyclic compounds having hiv integrase inhibitory activity |
| 08/13/2008 | EP1539714B1 8-hydroxy-1-oxo-tetrahydropyrrolopyrazine compounds useful as hiv integrase inhibitors |
| 08/13/2008 | EP1501803B1 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity |
| 08/13/2008 | EP1496905B1 Modulators of hedgehog signaling pathways, compositions and uses related thereto |
| 08/13/2008 | EP1495030B1 Non-steroidal progesterone receptor modulators |
| 08/13/2008 | EP1489088B1 Novel alpha-amino-n-(diaminophosphinyl)lactam derivative |
| 08/13/2008 | EP1489076B1 Cyclic hemiacetal derivative and use thereof |
| 08/13/2008 | EP1483290B1 Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments |
| 08/13/2008 | EP1476200A4 Compositions and method for regulation of calcium-dependent signalling in brain |
| 08/13/2008 | EP1467979B1 Fused heterocyclic compounds and analogs thereof modulators of nuclear hormone receptor function |
| 08/13/2008 | EP1452528B1 Xanthine oxidase inhibitors |
| 08/13/2008 | EP1436279B1 Chemical compounds |
| 08/13/2008 | EP1421946B1 A pharmaceutical composition for treating hiv infection |
| 08/13/2008 | EP1389098B1 Delivery of antipsychotics through an inhalation route |
| 08/13/2008 | EP1389097B1 Delivery of compounds for the treatment of parkinsons through an inhalation route |
| 08/13/2008 | EP1386923B1 Novel adenine derivatives |
| 08/13/2008 | EP1331924B1 Use of beta-carotene and lycopene for treating ageing symptoms via the inhibition of the expression of the metalloproteinase of type 1 of the extracellular matrix |
| 08/13/2008 | EP1272636B1 A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 08/13/2008 | EP1214453B1 Novel cell cycle checkpoint genes and proteins encoded thereby |
| 08/13/2008 | EP1200117B1 Lipoprotein lipase (lpl) variant therapeutics |
| 08/13/2008 | EP1200103B1 XENON AS NMDA ANTAGONIST for neuroprotection |
| 08/13/2008 | EP1177442B1 Determination of complex phospholipid/lipid structures using synthetic fluorescence-marked acylglycerides |
| 08/13/2008 | EP1133519B1 Functional antagonists of hedgehog activity |
| 08/13/2008 | CN101243184A Nucleic acid for treatment or prevention of immunodeficiency virus infection |
| 08/13/2008 | CN101243073A Piperazine-piperidine antagonists and agonists of the 5-HT1A receptor |
| 08/13/2008 | CN101241127A Sgk and Nedd used as diagnostic and therapeutic targets |
| 08/13/2008 | CN101240018A Peptides and related compounds having thrombopoietic activity |
| 08/13/2008 | CN101239061A New purpose of aminoperhydro-quinazoline compounds for eliminating clenbnterol in organisms |
| 08/13/2008 | CN100410236C Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps) |
| 08/13/2008 | CN100409845C Association and medicinal composition of CB1 receptor antagonist and application in preparing medicament for treating obesity |
| 08/13/2008 | CN100409841C Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration |
| 08/13/2008 | CN100409840C Application of inhibitors of glycogen synthase kinase-3 betta in preparing medicament for increasing bone formation |
| 08/13/2008 | CN100409770C Beverage for relieving summer heat and its preparation method |
| 08/12/2008 | US7411076 such as 2-chloro-N-(7-hydroxy-2-oxo-2H-1-benzopyran-3-yl)benzamide, used for intensifying the effects of cancer therapy based on DNA injury; protein kinase inhibitors; side effect reduction |
| 08/12/2008 | US7411072 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
| 08/12/2008 | US7411064 e.g. 4-chloro-3-(phenylsulfonyl)-1-(piperidin-4-ylmethyl)-1H-pyrazolo[4,3-b]pyridineI; antidepressant, anxiolytic agent, cognition activator; Alzheimer's disease, attention deficit disorder, schizophrenia; behavioral disorders, obsessive compulsive disorders, Parkinson's disease and epilepsy |
| 08/12/2008 | US7411055 Genetic engineering |
| 08/12/2008 | US7411043 Slo4 potassium channel proteins |
| 08/12/2008 | US7411041 DCRS5 polypeptides |
| 08/12/2008 | US7411004 Sulphones which modulate the action of gamma secretase |
| 08/12/2008 | US7410995 N-linked sulfonamide of heterocyclic thioesters for vision and memory disorders |
| 08/12/2008 | US7410994 (6-methanesulfonyl-3-phenylsulfanyl-1H-indol-2-yl)-methanol; cyclooxygenase, prostaglandin G/H synthase inhibitors; antiinflammatory and analgesic agents; autoimmune diseases; Alzheimer's disease and osteoporosis of women after menopause |
| 08/12/2008 | US7410991 Pyrazolidinone compounds as ligands of the prostaglandin EP2 and/or EP4 receptors |
| 08/12/2008 | US7410987 Treating pruritus or pain, particularly that caused by a rheumatic disease, by administering a 2-[o-(aminoalkoxy)phenyl])-3-acylbenzothiazoline, e.g., 3-Acetyl-6-chloro-2-[2-(3-(N-(2-hydroxyethyl)-N-isopropylamino)-propoxy)-5-methoxyphenyl]benzothiazoline |
| 08/12/2008 | US7410986 For therapy of inflammatory symptoms; tumors, ischemia and tumor |
| 08/12/2008 | US7410983 Combination of fenofibrate and coenzyme q10 for the treatment of endothelial dysfunction |
| 08/12/2008 | US7410981 low toxicity; 2-[methyl[[(R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimida zol-1-yl]carbonyl]amino]ethyl acetate; superior antiulcer activity, a gastric acid secretion inhibitory action, a mucosa-protecting action, an antiHelicobacter pylori action |
| 08/12/2008 | US7410972 Compounds |
| 08/12/2008 | US7410971 1,2-di(cyclic)substituted benzene compounds |
| 08/12/2008 | US7410955 Therapeutic use of agonist ligands specific to G2A receptor |
| 08/12/2008 | US7410946 Method for treating damage in intact skin comprising administering a composition comprising basic milk growth factors in amounts higher than those in milk |
| 08/12/2008 | US7410799 In vivo production and delivery of erythropoietin or insulinotropin for gene therapy |
| 08/12/2008 | US7410798 Culturing preferential cells; generate nutrient broth, inoculate with cells, propagate cells, recover cells |
| 08/12/2008 | US7410779 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide |
| 08/12/2008 | US7410777 Continously induced g-protein coupled receptors; membrane binding assays |
| 08/12/2008 | US7410774 Compounds modulating sister chromatid separation and method for identifying same |
| 08/12/2008 | US7410757 Expressing nucleic acid in tissue from occipital cortex of brain showing cell death as result of Alzheimer's Disease; isolating suppressor gene |
| 08/12/2008 | US7410652 Controlled release and taste masking oral pharmaceutical composition |
| 08/12/2008 | US7410651 Controlled release and taste masking oral pharmaceutical composition |
| 08/12/2008 | US7410641 Hybridoma and monoclonal antibodies produced; insulin-like growth factor (IGF); diagnosis, treatment, prevention of diabetes and metabolic disorders |
| 08/12/2008 | US7410639 Neovascularization; platelet derived growth factors; vascular permeability factors; wound healing agents; antitumor/antiproliferative agents; antisense agents; for treatment of intestinal malabsorption syndrome |